Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Herston, Queensland, Australia.
Centre de recherche en Epidémiologie et Santé des Populations, Faculté de médecine-Université Paris-Sud, Faculté de médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.
J Invest Dermatol. 2018 Aug;138(8):1816-1824. doi: 10.1016/j.jid.2017.12.036. Epub 2018 Mar 7.
A proportion of cutaneous melanomas display neval remnants on histologic examination. Converging lines of epidemiologic and molecular evidence suggest that melanomas arising from nevus precursors differ from melanomas arising de novo. In a large, population-based study comprising 636 cutaneous melanomas subjected to dermatopathology review, we explored the molecular, host, and environmental factors associated with the presence of neval remnants. We found that nevus-associated melanomas were significantly associated with younger age at presentation, non-brown eye color, trunk site, thickness of less than 0.5 mm, and BRAF mutation. Compared with patients with de novo melanomas, those with nevus-associated tumors were more likely to self-report many moles on their skin as a teenager (odds ratio = 1.94, 95% confidence interval = 1.01-3.72) but less likely to report many facial freckles (odds ratio = 0.49, 95% confidence interval = 0.25-0.96). They also had high total nevus counts (odds ratio = 2.18, 95% confidence interval = 1.26-3.78). On histologic examination, nevus-associated melanomas exhibited less dermal elastosis in adjacent skin compared with de novo melanomas (odds ratio = 0.55, 95% confidence interval = 0.30-1.01). These epidemiologic data accord with the emerging molecular paradigm that nevus-associated melanomas arise through a distinct sequence of causal events that differ from those leading to other cutaneous melanomas.
一部分皮肤黑色素瘤在组织学检查中显示有痣残余。流行病学和分子证据的趋同表明,源自痣前体的黑色素瘤与新发性黑色素瘤不同。在一项包含 636 例经皮肤科病理检查的皮肤黑色素瘤的大型基于人群的研究中,我们探讨了与痣残余存在相关的分子、宿主和环境因素。我们发现,与痣相关的黑色素瘤与发病时年龄较小、非棕色眼睛颜色、躯干部位、厚度小于 0.5 毫米以及 BRAF 突变显著相关。与新发黑色素瘤患者相比,具有痣相关肿瘤的患者在青少年时期更有可能自述皮肤上有许多痣(优势比=1.94,95%置信区间=1.01-3.72),但不太可能报告有许多面部雀斑(优势比=0.49,95%置信区间=0.25-0.96)。他们的总痣计数也较高(优势比=2.18,95%置信区间=1.26-3.78)。在组织学检查中,与新发黑色素瘤相比,与痣相关的黑色素瘤在相邻皮肤中表现出较少的真皮弹性组织减少(优势比=0.55,95%置信区间=0.30-1.01)。这些流行病学数据与新兴的分子范例一致,即与痣相关的黑色素瘤通过不同的因果事件序列产生,这些事件与导致其他皮肤黑色素瘤的事件不同。